{"id":1646,"date":"2024-12-30T16:56:51","date_gmt":"2024-12-30T16:56:51","guid":{"rendered":"https:\/\/journal.nncf.kz\/?p=1646"},"modified":"2025-02-04T10:58:51","modified_gmt":"2025-02-04T10:58:51","slug":"peculiarities-of-the-course-hepatitis-b-and-c-infections-in-hemodialysis-patients-a-literature-review","status":"publish","type":"post","link":"https:\/\/journal.nncf.kz\/en\/peculiarities-of-the-course-hepatitis-b-and-c-infections-in-hemodialysis-patients-a-literature-review\/","title":{"rendered":"PECULIARITIES OF THE COURSE HEPATITIS B AND C INFECTIONS IN HEMODIALYSIS PATIENTS: A LITERATURE REVIEW"},"content":{"rendered":"

Received: 25.11.2024 Accepted: 09.12.2024 Published online: 30.12.2024
\nDOI: 10.26212\/2227-1937.2025.83.21.004<\/a>
\n\u0423\u0414\u041a: 616.36-002+615.38
\nPECULIARITIES OF THE COURSE HEPATITIS B AND C INFECTIONS IN HEMODIALYSIS PATIENTS: A LITERATURE REVIEW
\nArina Yespotayeva1,2, ORCID: https:\/\/orcid.org\/0000-0003-2582-1211
\nKairat Kabulbayev2, https:\/\/orcid.org\/: 0000-0002-5977-1569
\nAlmagul Kurmanova1, https:\/\/orcid.org\/: 0000-0002-1859-3903
\nAbduzhappar Gaipov3, https:\/\/orcid.org\/: 0000-0002-9844-8772
\nAlexander V. Nersesov2, https:\/\/orcid.org\/0000-0002-8601-3966
\nAbay Shepetov2, https:\/\/orcid.org\/0000-0002-2201-5946
\nGulnar Chingayeva2, https:\/\/orcid.org\/0000-0001-6267-5351
\nNagima Mustapayeva2
\n, https:\/\/orcid.org\/0000-0001-5963-7645
\nGainutdin Aisulu2, https:\/\/orcid.org\/0000-0002-5629-3848
\n1Al-Farabi Kazakh National University, Almaty, Kazakhstan
\n2S.D AsfendiyarovKazakh National Medical University, Almaty, Kazakhstan
\n3Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
\nResume
\nBackground. Hepatitis B (HBV) and Hepatitis C (HCV) present significant challenges for hemodialysis patients due to
\nimpaired immunity and frequent blood exposures. Advancements in antiviral therapies, infection control measures, and
\nvaccination are critical for reducing their burden.
\nPurpose of the review. To evaluate the epidemiology, management, and prevention of HBV and HCV in hemodialysis
\npatients. The review synthesized current research on transmission, infection control, antiviral therapies, and vaccination
\nstrategies, emphasizing their role in improving patient outcomes.
\nMaterials and methods. A systematic review of PubMed, Google Scholar, and Cochrane Library (2000\u20132022) using
\nkeywords like “Hepatitis B,” “Hepatitis C,” “Hemodialysis,” “Infection Control,” and “Vaccination.”
\nConclusions: HBV and HCV remain critical concerns in hemodialysis settings. Advances in therapy, combined with
\npreventive measures, are essential for better patient outcomes and infection control.
\nKeywords: Hepatitis B, Hepatitis C, Hemodialysis, Infection Control, Antiviral Therapy, Vaccination, Epidemiology.<\/p>\n

\r\n\t\"\"\r\n\r\n\t
\r\n\t\t\u0421\u043a\u0430\u0447\u0430\u0442\u044c: PECULIARITIES OF THE COURSE HEPATITIS B AND C INFECTIONS IN HEMODIALYSIS PATIENTS: A LITERATURE REVIEW<\/a>\r\n\t\t
<\/div>\r\n\t\t
\u0421\u043a\u0430\u0447\u0430\u043d\u043e: 133, \u0440\u0430\u0437\u043c\u0435\u0440: 684.4 KB<\/div>\r\n\t<\/div>\r\n\t\r\n<\/div>\r\n\r\n